| Financial Year |
March 31 2023 |
| Monetary Funds |
1,374,574,169.61 |
| Held-for-trading Financial Assets |
376,834,219.74 |
| Notes Receivable |
237,322,817.86 |
| Accounts Receivable |
594,958,161.82 |
| Advances to Suppliers |
7,861,508.79 |
| Other Receivables |
48,170,540.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
411,666,659.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,668,562.51 |
| Total Current Assets |
3,069,247,325.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
572,283,411.92 |
| Investment Properties |
-- |
| Fixed Assetes |
802,862,911.87 |
| Under-construction Projects |
396,516,994.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
146,118,548.72 |
| R&D expenses |
428,528.88 |
| Goodwill |
139,460,474.38 |
| Long-Term Deferred and Prepaid Expenses |
17,644,299.11 |
| Deferred Income Tax Assets |
48,851,224.20 |
| Other Non-Current Assets |
67,990,184.13 |
| Sub-Total of Non-Current Assets |
2,464,405,956.89 |
| Total Assets |
5,533,653,282.09 |
| Short-Term Loans |
141,766,760.65 |
| Trading Financial liabilities |
-- |
| Notes Payable |
228,366,450.24 |
| Accounts Payable |
395,236,106.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
69,373,121.82 |
| Taxes Payable |
25,208,777.91 |
| Interest Payable |
-276,824.06 |
| Dividend Payable |
-- |
| Other payables |
55,705,035.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
73,223,909.73 |
| Other Current Liabilities |
17,197.05 |
| Sub-Total of Current Liabilities |
990,568,556.51 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
37,610,861.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
142,424,153.13 |
| Total Liabilities |
1,132,992,709.64 |
| Paid-In Capital(Or Share Stock) |
422,157,000.00 |
| Capital Surplus |
2,004,378,541.43 |
| Surplus Reserve |
211,078,500.00 |
| LESS:Treasury Stock |
207,932,617.65 |
| Undistributed Profits |
1,730,446,951.82 |
| Minority Stockholder's Interest |
237,499,683.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,163,160,888.96 |
| Owner's Equity（Stockholder's Equity） |
4,400,660,572.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,533,653,282.09 |
